Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123987) titled 'Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Mohamed Hosny Ismail Easa
Condition:
Post Herpetic Neuralgia (PHN)
Intervention:
Device: transcutaneous auricular vagus nerve stimulation (taVNS)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: September 1, 2025
Target Sample Size: 34
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/sh...